Polynovo Ltd

Price Chart

Risk-Adjusted Performance

Also Listed On

Polynovo Ltd (PNV) Price Performance

Polynovo Ltd (PNV) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at AUD1.02, up 1.49% from the previous close.

Over the past year, PNV has traded between a low of AUD0.88 and a high of AUD1.67. The stock has lost 9.3% over this period. It is currently 38.6% below its 52-week high.

Polynovo Ltd has a market capitalization of $708.11M, with a price-to-earnings ratio of 102.50.

About Polynovo Ltd

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.